227 related articles for article (PubMed ID: 26209442)
1. Autoregulatory function of interleukin-10-producing pre-naïve B cells is defective in systemic lupus erythematosus.
Sim JH; Kim HR; Chang SH; Kim IJ; Lipsky PE; Lee J
Arthritis Res Ther; 2015 Jul; 17(1):190. PubMed ID: 26209442
[TBL] [Abstract][Full Text] [Related]
2. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
al-Janadi M; Raziuddin S
J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
4. Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus.
Gao N; Dresel J; Eckstein V; Gellert R; Störch H; Venigalla RK; Schwenger V; Max R; Blank N; Lorenz HM; Tretter T
Arthritis Rheumatol; 2014 Oct; 66(10):2849-61. PubMed ID: 24942956
[TBL] [Abstract][Full Text] [Related]
5. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus.
Terrier B; Costedoat-Chalumeau N; Garrido M; Geri G; Rosenzwajg M; Musset L; Klatzmann D; Saadoun D; Cacoub P
J Rheumatol; 2012 Sep; 39(9):1819-28. PubMed ID: 22859347
[TBL] [Abstract][Full Text] [Related]
7. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
8. Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients.
Fleischer V; Sieber J; Fleischer SJ; Shock A; Heine G; Daridon C; Dörner T
Arthritis Res Ther; 2015 Jul; 17(1):185. PubMed ID: 26183319
[TBL] [Abstract][Full Text] [Related]
9. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6
Facciotti F; Larghi P; Bosotti R; Vasco C; Gagliani N; Cordiglieri C; Mazzara S; Ranzani V; Rottoli E; Curti S; Penatti A; Karnani B; Kobayashi Y; Crosti M; Bombaci M; van Hamburg JP; Rossetti G; Gualtierotti R; Gerosa M; Gatti S; Torretta S; Pignataro L; Tas SW; Abrignani S; Pagani M; Grassi F; Meroni PL; Flavell RA; Geginat J
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7305-7316. PubMed ID: 32184325
[TBL] [Abstract][Full Text] [Related]
11. Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus.
Wang L; Zhao P; Ma L; Shan Y; Jiang Z; Wang J; Jiang Y
J Rheumatol; 2014 Sep; 41(9):1781-92. PubMed ID: 25028374
[TBL] [Abstract][Full Text] [Related]
12. Signaling Lymphocytic Activation Molecule Family Member 1 Engagement Inhibits T Cell-B Cell Interaction and Diminishes Interleukin-6 Production and Plasmablast Differentiation in Systemic Lupus Erythematosus.
Karampetsou MP; Comte D; Suárez-Fueyo A; Katsuyama E; Yoshida N; Kono M; Kyttaris VC; Tsokos GC
Arthritis Rheumatol; 2019 Jan; 71(1):99-108. PubMed ID: 30058241
[TBL] [Abstract][Full Text] [Related]
13. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
[TBL] [Abstract][Full Text] [Related]
14. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus.
Tanaka Y; Saito K; Shirakawa F; Ota T; Suzuki H; Eto S; Yamashita U
J Immunol; 1988 Nov; 141(9):3043-9. PubMed ID: 3262675
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of TLR2 in CD4(+) T cells from SLE patients enhances immune reactivity and promotes IL-17 expression through histone modifications.
Liu Y; Liao J; Zhao M; Wu H; Yung S; Chan TM; Yoshimura A; Lu Q
Eur J Immunol; 2015 Sep; 45(9):2683-93. PubMed ID: 26079624
[TBL] [Abstract][Full Text] [Related]
16. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
Fritsch-Stork R; Müllegger D; Skriner K; Jahn-Schmid B; Smolen JS; Steiner G
Arthritis Res Ther; 2006; 8(4):R118. PubMed ID: 16859514
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
[TBL] [Abstract][Full Text] [Related]
18. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of microRNA-155 increases IL-21 mediated STAT3 signaling and IL-21 production in systemic lupus erythematosus.
Rasmussen TK; Andersen T; Bak RO; Yiu G; Sørensen CM; Stengaard-Pedersen K; Mikkelsen JG; Utz PJ; Holm CK; Deleuran B
Arthritis Res Ther; 2015 Jun; 17(1):154. PubMed ID: 26055806
[TBL] [Abstract][Full Text] [Related]
20. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.
Llorente L; Zou W; Levy Y; Richaud-Patin Y; Wijdenes J; Alcocer-Varela J; Morel-Fourrier B; Brouet JC; Alarcon-Segovia D; Galanaud P; Emilie D
J Exp Med; 1995 Mar; 181(3):839-44. PubMed ID: 7869046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
